| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction.
|
Eur Heart J
|
2009
|
1.61
|
|
2
|
The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes.
|
Am Heart J
|
2009
|
1.57
|
|
3
|
Factors influencing underutilization of evidence-based therapies in women.
|
Eur Heart J
|
2011
|
1.56
|
|
4
|
Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary Events.
|
Heart
|
2010
|
1.53
|
|
5
|
Relation between hemoglobin level and recurrent myocardial ischemia in acute coronary syndromes detected by continuous electrocardiographic monitoring.
|
Am J Cardiol
|
2010
|
1.51
|
|
6
|
Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled trial.
|
Heart
|
2014
|
1.41
|
|
7
|
Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cardiovascular outcomes in chronic dialysis patients: a population-based cohort study.
|
Arch Intern Med
|
2012
|
1.40
|
|
8
|
Local hospital vs. core-laboratory interpretation of the admission electrocardiogram in acute coronary syndromes: increased mortality in patients with unrecognized ST-elevation myocardial infarction.
|
Eur Heart J
|
2007
|
1.38
|
|
9
|
Bridging the gender gap: Insights from a contemporary analysis of sex-related differences in the treatment and outcomes of patients with acute coronary syndromes.
|
Am Heart J
|
2012
|
1.33
|
|
10
|
Cardiovascular magnetic resonance for the diagnosis of acute myocarditis: prospects for detecting myocardial inflammation.
|
J Am Coll Cardiol
|
2005
|
1.11
|
|
11
|
Use of cardiac catheterization for non-ST-segment elevation acute coronary syndromes according to initial risk: reasons why physicians choose not to refer their patients.
|
Arch Intern Med
|
2008
|
1.09
|
|
12
|
Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada.
|
Am Heart J
|
2009
|
1.07
|
|
13
|
Relation between obesity and the attainment of optimal blood pressure and lipid targets in high vascular risk outpatients.
|
Am J Cardiol
|
2010
|
0.99
|
|
14
|
Age-related differences in the management and outcome of patients with acute coronary syndromes.
|
Am Heart J
|
2006
|
0.99
|
|
15
|
Missed opportunities for the secondary prevention of cardiovascular disease in Canada.
|
Can J Cardiol
|
2007
|
0.99
|
|
16
|
Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromes.
|
Am J Cardiol
|
2009
|
0.98
|
|
17
|
Optimal medical therapy for non-ST-segment-elevation acute coronary syndromes: exploring why physicians do not prescribe evidence-based treatment and why patients discontinue medications after discharge.
|
Circ Cardiovasc Qual Outcomes
|
2010
|
0.96
|
|
18
|
Prevalence and non-invasive predictors of left main or three-vessel coronary disease: evidence from a collaborative international meta-analysis including 22 740 patients.
|
Heart
|
2012
|
0.96
|
|
19
|
Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals?
|
Stroke
|
2009
|
0.94
|
|
20
|
Treatment and outcomes of patients with suspected acute coronary syndromes in relation to initial diagnostic impressions (insights from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE]).
|
Am J Cardiol
|
2012
|
0.93
|
|
21
|
Comparative assessment of 2-dimensional echocardiography vs cardiac magnetic resonance imaging in measuring left ventricular mass in patients with and without end-stage renal disease.
|
Can J Cardiol
|
2012
|
0.93
|
|
22
|
Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes.
|
Am Heart J
|
2010
|
0.90
|
|
23
|
Potential clinical impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for cardioverter defibrillator implantation.
|
J Cardiovasc Magn Reson
|
2012
|
0.90
|
|
24
|
Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes.
|
Am Heart J
|
2011
|
0.89
|
|
25
|
Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularization.
|
Am Heart J
|
2010
|
0.88
|
|
26
|
Fibrinogen and left ventricular myocardial systolic function: The Multi-Ethnic Study of Atherosclerosis (MESA).
|
Am Heart J
|
2010
|
0.87
|
|
27
|
Do clinical factors explain persistent sex disparities in the use of acute reperfusion therapy in STEMI in Sweden and Canada?
|
Eur Heart J Acute Cardiovasc Care
|
2013
|
0.86
|
|
28
|
Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
|
Am J Cardiol
|
2005
|
0.86
|
|
29
|
Underuse of evidence-based treatment partly explains the worse clinical outcome in diabetic patients with acute coronary syndromes.
|
Am Heart J
|
2006
|
0.84
|
|
30
|
Regression of left ventricular mass following conversion from conventional hemodialysis to thrice weekly in-centre nocturnal hemodialysis.
|
BMC Nephrol
|
2012
|
0.84
|
|
31
|
Patient age, ethnicity, medical history, and risk factor profile, but not drug insurance coverage, predict successful attainment of glycemic targets: Time 2 Do More Quality Enhancement Research Initiative (T2DM QUERI).
|
Diabetes Care
|
2010
|
0.83
|
|
32
|
The differential association between various anthropometric indices of obesity and subclinical atherosclerosis.
|
Atherosclerosis
|
2009
|
0.83
|
|
33
|
Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada.
|
Nephrol Dial Transplant
|
2011
|
0.82
|
|
34
|
The role of B vitamins in the management of heart failure.
|
Nutr Clin Pract
|
2012
|
0.81
|
|
35
|
Has the ClOpidogrel and Metoprolol in Myocardial Infarction Trial (COMMIT) of early β-blocker use in acute coronary syndromes impacted on clinical practice in Canada? Insights from the Global Registry of Acute Coronary Events (GRACE).
|
Am Heart J
|
2011
|
0.81
|
|
36
|
The association between prior use of aspirin and/or warfarin and the in-hospital management and outcomes in patients presenting with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE).
|
Can J Cardiol
|
2011
|
0.81
|
|
37
|
Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes.
|
Am Heart J
|
2009
|
0.81
|
|
38
|
Canada Acute Coronary Syndrome Risk Score: a new risk score for early prognostication in acute coronary syndromes.
|
Am Heart J
|
2013
|
0.81
|
|
39
|
Differences between local hospital and core laboratory interpretation of the admission electrocardiogram in patients with acute coronary syndromes and their relation to outcome.
|
Am J Cardiol
|
2007
|
0.81
|
|
40
|
Relation between previous angiotensin-converting enzyme inhibitor use and in-hospital outcomes in acute coronary syndromes.
|
Am J Cardiol
|
2011
|
0.81
|
|
41
|
Comparison of baseline characteristics, management and outcome of patients with non-ST-segment elevation acute coronary syndrome in versus not in clinical trials.
|
Am J Cardiol
|
2010
|
0.81
|
|
42
|
Underutilization of clopidogrel and glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute coronary syndrome patients: the Canadian global registry of acute coronary events (GRACE) experience.
|
Am Heart J
|
2009
|
0.80
|
|
43
|
Use and timing of coronary angiography and associated in-hospital outcomes in Canadian non-ST-segment elevation myocardial infarction patients: insights from the Canadian Global Registry of Acute Coronary Events.
|
Can J Cardiol
|
2013
|
0.80
|
|
44
|
Reperfusion strategies and outcomes of ST-segment elevation myocardial infarction patients in Canada: observations from the Global Registry of Acute Coronary Events (GRACE) and the Canadian Registry of Acute Coronary Events (CANRACE).
|
Can J Cardiol
|
2011
|
0.80
|
|
45
|
Management and outcome of acute coronary syndrome patients in relation to prior history of atrial fibrillation.
|
Can J Cardiol
|
2012
|
0.79
|
|
46
|
Evaluation of left ventricular ejection fraction in non-ST-segment elevation acute coronary syndromes and its relationship to treatment.
|
Am Heart J
|
2010
|
0.79
|
|
47
|
Correlates of left ventricular mass in chronic hemodialysis recipients.
|
Int J Cardiovasc Imaging
|
2013
|
0.79
|
|
48
|
Prognostic significance of presenting blood pressure in non-ST-segment elevation acute coronary syndrome in relation to prior history of hypertension.
|
Am Heart J
|
2013
|
0.78
|
|
49
|
Disparities in management patterns and outcomes of patients with non-ST-elevation acute coronary syndrome with and without a history of cerebrovascular disease.
|
Am J Cardiol
|
2010
|
0.78
|
|
50
|
Thiamin deficiency and heart failure: the current knowledge and gaps in literature.
|
Heart Fail Rev
|
2015
|
0.78
|
|
51
|
Quantitative troponin elevation does not provide incremental prognostic value beyond comprehensive risk stratification in patients with non-ST-segment elevation acute coronary syndromes.
|
Am Heart J
|
2008
|
0.78
|
|
52
|
Assessment of right ventricular volumes and function using cardiovascular magnetic resonance cine imaging after atrial redirection surgery for complete transposition of the great arteries.
|
Int J Cardiovasc Imaging
|
2012
|
0.78
|
|
53
|
QRS prolongation in patients with acute coronary syndromes.
|
Am Heart J
|
2010
|
0.78
|
|
54
|
Temporal trends and referral factors for cardiac rehabilitation post-acute coronary syndrome in ontario: insights from the Canadian Global Registry of Acute Coronary Events.
|
Can J Cardiol
|
2013
|
0.77
|
|
55
|
Management and outcomes of non-ST elevation acute coronary syndromes in relation to previous use of antianginal therapies (from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE]).
|
Am J Cardiol
|
2013
|
0.77
|
|
56
|
Temporal patterns of lipid testing and statin therapy in acute coronary syndrome patients (from the Canadian GRACE Experience).
|
Am J Cardiol
|
2012
|
0.77
|
|
57
|
Efficacy and safety of enoxaparin compared with unfractionated heparin in the pharmacoinvasive management of acute ST-segment elevation myocardial infarction: Insights from the TRANSFER-AMI trial.
|
Am Heart J
|
2012
|
0.76
|
|
58
|
Use of clopidogrel post-coronary artery bypass surgery in canadian patients with acute coronary syndromes.
|
Can J Cardiol
|
2011
|
0.76
|
|
59
|
Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary Events.
|
Am Heart J
|
2010
|
0.75
|
|
60
|
Reviparin in acute myocardial infarction.
|
JAMA
|
2005
|
0.75
|
|
61
|
Excess dosing of antithrombotic therapy in non-ST-segment elevation acute coronary syndromes.
|
JAMA
|
2006
|
0.75
|
|
62
|
Percutaneous coronary intervention vs thrombolysis for ST-elevation myocardial infarction.
|
JAMA
|
2007
|
0.75
|
|
63
|
Paraoxonase 1 Phenotype and Mass in South Asian versus Caucasian Renal Transplant Recipients.
|
J Lipids
|
2012
|
0.75
|
|
64
|
Multimodality imaging in the evaluation of cardiovascular manifestations of malignancy.
|
Cardiol Res Pract
|
2011
|
0.75
|
|
65
|
Better outcome of myocardial infarction in hospitals with PCI facilities--is it because of more PCIs?
|
Arch Intern Med
|
2008
|
0.75
|
|
66
|
Pre-hospital cardiac arrest in acute coronary syndromes: insights from the global registry of acute coronary events and the canadian registry of acute coronary events.
|
Cardiology
|
2013
|
0.75
|
|
67
|
Misinterpretation of electrocardiograms and cardiac catheterization laboratory activations.
|
JAMA
|
2008
|
0.75
|
|
68
|
Sex differences in the benefits of the guidelines applied in practice project: are they due to sex?
|
Arch Intern Med
|
2006
|
0.75
|
|
69
|
In-center nocturnal hemodialysis.
|
Semin Dial
|
2014
|
0.75
|
|
70
|
Provision of gastroprotective medication and bleeding risk following acute coronary syndrome.
|
J Invasive Cardiol
|
2013
|
0.75
|
|
71
|
Relationship between changes in blood pressure and left ventricular mass over 1 year in end-stage renal disease.
|
J Hypertens
|
2017
|
0.75
|
|
72
|
Comparative prognostic value of T-wave inversion and ST-segment depression on the admission electrocardiogram in non-ST-segment elevation acute coronary syndromes.
|
Am Heart J
|
2013
|
0.75
|
|
73
|
Usefulness of quantitative versus qualitative ST-segment depression for risk stratification of non-ST elevation acute coronary syndromes in contemporary clinical practice.
|
Am J Cardiol
|
2008
|
0.75
|
|
74
|
Management of risk factors among ambulatory patients at high cardiovascular risk in Canada: a follow-up study.
|
Can J Cardiol
|
2013
|
0.75
|
|
75
|
Clinical implications of a next-day follow-up electrocardiogram in patients with non-ST elevation acute coronary syndromes.
|
Am Heart J
|
2008
|
0.75
|
|
76
|
Multimodality imaging in the preoperative diagnosis of lipomatous hypertrophy.
|
Can J Cardiol
|
2012
|
0.75
|
|
77
|
Short Duration vs Standard Duration of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents - A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials.
|
J Invasive Cardiol
|
2016
|
0.75
|
|
78
|
Impact of delayed presentation on management and outcome of non-ST-elevation acute coronary syndromes.
|
Am Heart J
|
2008
|
0.75
|
|
79
|
Efficacy of early invasive management post-fibrinolysis in men versus women with ST-elevation myocardial infarction: a subgroup analysis from Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).
|
Am Heart J
|
2012
|
0.75
|
|
80
|
Multimodality imaging for resuscitated sudden cardiac death.
|
J Cardiovasc Med (Hagerstown)
|
2015
|
0.75
|
|
81
|
Reply.
|
J Hypertens
|
2017
|
0.75
|
|
82
|
Prognostic utility of quantifying evolutionary ST-segment depression on early follow-up electrocardiogram in patients with non-ST-segment elevation acute coronary syndromes.
|
Eur Heart J
|
2009
|
0.75
|
|
83
|
Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non-ST-elevation acute coronary syndromes.
|
Am Heart J
|
2011
|
0.75
|
|
84
|
The management of left ventricular systolic dysfunction in patients with advanced chronic kidney disease.
|
J Nephrol
|
2010
|
0.75
|
|
85
|
Persistent left superior vena cava with retrograde drainage from the left atrium into the left brachiocephalic vein.
|
J Am Coll Cardiol
|
2011
|
0.75
|
|
86
|
Reply: Coronary Artery Disease Affects Symptomatology of Aortic Valve Stenosis.
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
87
|
Treatment and outcomes of non-ST elevation acute coronary syndromes in relation to burden of pre-existing vascular disease.
|
Int J Cardiol
|
2013
|
0.75
|